Akribion Therapeutics
PrivateLast Round
Seed
Feb 4, 2025
Total Funding Raised
$8.64M
Company Overview
Akribion Therapeutics is a biotechnology company that develops a unique, RNA-guided, nuclease-based technology for programmable cell depletion.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akribion Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Akribion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 4, 2025 |
Key People
Founding team and executive leadership
Akribion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Beteiligungs-GmbH | Seed |
| Hessen Kapital I | Seed |
| RV Invest | Seed |
| CARMA FUND | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2025
BioTech startup emerges from stealth mode.
- Feb 4, 2025
$8.64M raised in Seed round.
Akribion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Akribion Therapeutics's valuation, stock price, and market status.
